Ethinyl estradiol (EE) is still used to some extent as hormonal replacement therapy (HRT) in
the climacteric period. As regards oral contraception, it is well known that the induced …

Introduction Contraceptives containing ethinylestradiol (EE) induce changes in the
coagulation system and are associated with a risk of venous thromboembolism. However …

Context: The use of combined hormonal contraceptives with ethinyl estradiol (EE) and a
progestin results in alterations in potential biomarkers of venous thromboembolism risk …

We compared the effects on hemostatic variables of transdermal estradiol and oral equine
conjugated estrogens (CEE), both combined with medroxyprogesterone acetate, in 40 …

The effects of oral and transdermal administration of estrogen replacement therapy (ERT)
have been fairly well investigated regarding lipoprotein and carbohydrate metabolism, while …

Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …

Epidemiological studies have shown that hormone therapy (HT) increases the risk of venous
thromboembolism in post menopausal women. The mechanism of this increased risk is …

The effects on the haemostatic mechanism of oestrogen therapy, given to prevent bone loss
in post-menopausal women, have been investigated. Oestriol succinate was given orally to …

In a 6-month, randomized, double-blind study the effects of two combined oral
contraceptives containing 150 μg desogestrel and either 20 or 30 μg ethinylestradiol on …

An association between an increase in the incidence of thromboembolic disease and the
use of combined oral contraceptives has been shown by several epidemiologic studies …